Rimcazole
- none
- 9-{3-[(3R,5S)-3,5-Dimethylpiperazin-1-yl]propyl}-9H-carbazole
- 75859-04-0 Y
- 53389
- 48221 N
- C3N1PS8CX1
- ChEMBL275707 N
- DTXSID7048162
- Interactive image
- C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
- InChI=1S/C21H27N3/c1-16-14-23(15-17(2)22-16)12-7-13-24-20-10-5-3-8-18(20)19-9-4-6-11-21(19)24/h3-6,8-11,16-17,22H,7,12-15H2,1-2H3/t16-,17+ N
- Key:GUDVQJXODNJRIJ-CALCHBBNSA-N N
Rimcazole is an antagonist[1] of the sigma receptor[2] as well as a dopamine reuptake inhibitor.[3] Sigma receptors are thought to be involved in the drug psychosis that can be induced by some drugs such as phencyclidine and cocaine, and rimcazole was originally researched as a potential antipsychotic with a different mechanism of action to traditional antipsychotic drugs. Trials proved inconclusive and rimcazole was not pursued for this application, but other sigma antagonists continue to be researched for a variety of potential applications.[4] Rimcazole has been shown to reduce the effects of cocaine,[5] and analogues of rimcazole have been shown to be highly effective at blocking the convulsions caused by cocaine overdose in animal models.[6]
References
- ^ Gilmore DL, Liu Y, Matsumoto RR (2004). "Review of the pharmacological and clinical profile of rimcazole". CNS Drug Reviews. 10 (1): 1–22. doi:10.1111/j.1527-3458.2004.tb00001.x. PMC 6741722. PMID 14978511.
- ^ Eaton MJ, Lookingland KJ, Moore KE (September 1996). "The sigma ligand rimcazole activates noradrenergic neurons projecting to the paraventricular nucleus and increases corticosterone secretion in rats". Brain Research. 733 (2): 162–166. doi:10.1016/0006-8993(96)00290-9. PMID 8891298. S2CID 42885767.
- ^ Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, Newman AH (December 1997). "Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter". Journal of Medicinal Chemistry. 40 (26): 4340–4346. doi:10.1021/jm9705519. PMID 9435903.
- ^ Volz HP, Stoll KD (November 2004). "Clinical trials with sigma ligands". Pharmacopsychiatry. 37 (Suppl 3): S214–S220. doi:10.1055/s-2004-832680. PMID 15547788. S2CID 260238757.
- ^ Katz JL, Libby TA, Kopajtic T, Husbands SM, Newman AH (May 2003). "Behavioral effects of rimcazole analogues alone and in combination with cocaine". European Journal of Pharmacology. 468 (2): 109–119. doi:10.1016/s0014-2999(03)01638-8. PMID 12742518.
- ^ Matsumoto RR, Hewett KL, Pouw B, Bowen WD, Husbands SM, Cao JJ, Newman AH (December 2001). "Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters". Neuropharmacology. 41 (7): 878–886. doi:10.1016/s0028-3908(01)00116-2. PMID 11684152. S2CID 44328858.
- v
- t
- e
(DRIsTooltip Dopamine reuptake inhibitors)
(NRIsTooltip Norepinephrine reuptake inhibitors)
(SRIsTooltip Serotonin reuptake inhibitors)
- Amiodarone
- Amphetamines (e.g., amphetamine, methamphetamine, MDMA)
- APP
- AZIK
- Bietaserpine
- Deserpidine
- Deutetrabenazine
- Dihydrotetrabenazine
- Efavirenz
- GBR-12935
- GZ-793A
- Ibogaine
- Ketanserin
- Lobeline
- Methoxytetrabenazine
- Reserpine
- Rose bengal
- Tetrabenazine
- Valbenazine
- Vanoxerine (GBR-12909)
- DAT enhancers: Luteolin
- DAT modulators: Agonist-like: SoRI-9804
- SoRI-20040; Antagonist-like: SoRI-20041
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e